CNSP analyst estimates

CNS Pharmaceuticals (CNSP) analyst ratings, the average price target and its range, and every firm's latest call.

CNSP analyst ratings and price targets

DateFirmCallTarget
Sep 10, 2024Maxim GroupMaxim Group Upgrades CNS Pharmasceuticals Inc. (CNSP) to Buy, 'Berubicin Glioblastoma Data is Coming into View'$0.50